Literature DB >> 33737508

Cognitive impairment in schizophrenia: relationships with cortical thickness in fronto-temporal regions, and dissociability from symptom severity.

Erkan Alkan1, Geoff Davies2, Simon L Evans3.   

Abstract

Cognitive impairments are a core and persistent characteristic of schizophrenia with implications for daily functioning. These show only limited response to antipsychotic treatment and their neural basis is not well characterised. Previous studies point to relationships between cortical thickness and cognitive performance in fronto-temporal brain regions in schizophrenia patients (SZH). There is also evidence that these relationships might be independent of symptom severity, suggesting dissociable disease processes. We set out to explore these possibilities in a sample of 70 SZH and 72 age and gender-matched healthy controls (provided by the Center of Biomedical Research Excellence (COBRE)). Cortical thickness within fronto-temporal regions implicated by previous work was considered in relation to performance across various cognitive domains (from the MATRICS Cognitive Battery). Compared to controls, SZH had thinner cortices across most fronto-temporal regions and significantly lower performance on all cognitive domains. Robust relationships with cortical thickness were found: visual learning and attention performance correlated with bilateral superior and middle frontal thickness in SZH only. Correlations between attention performance and right transverse temporal thickness were also specific to SZH. Findings point to the importance of these regions for cognitive performance in SZH, possibly reflecting compensatory processes and/or aberrant connectivity. No links to symptom severity were observed in these regions, suggesting these relationships are dissociable from underlying psychotic symptomology. Findings enhance understanding of the brain structural underpinnings and possible aetiology of cognitive impairment in SZH.

Entities:  

Year:  2021        PMID: 33737508      PMCID: PMC7973472          DOI: 10.1038/s41537-021-00149-0

Source DB:  PubMed          Journal:  NPJ Schizophr        ISSN: 2334-265X


  79 in total

Review 1.  Neurocognition: clinical and functional outcomes in schizophrenia.

Authors:  Martin Lepage; Michael Bodnar; Christopher R Bowie
Journal:  Can J Psychiatry       Date:  2014-01       Impact factor: 4.356

Review 2.  The research evidence for schizophrenia as a neurodevelopmental disorder.

Authors:  Bjorn Rishovd Rund
Journal:  Scand J Psychol       Date:  2018-02

3.  Functional imaging of the hemodynamic sensory gating response in schizophrenia.

Authors:  Andrew R Mayer; David Ruhl; Flannery Merideth; Josef Ling; Faith M Hanlon; Juan Bustillo; Jose Cañive
Journal:  Hum Brain Mapp       Date:  2012-03-28       Impact factor: 5.038

4.  The Relationship of Intellectual Functioning and Cognitive Performance to Brain Structure in Schizophrenia.

Authors:  Letícia Sanguinetti Czepielewski; Lei Wang; Clarissa S Gama; Deanna M Barch
Journal:  Schizophr Bull       Date:  2017-03-01       Impact factor: 9.306

5.  Gender differences measured by the MATRICS consensus cognitive battery in chronic schizophrenia patients.

Authors:  Baohua Zhang; Mei Han; Shuping Tan; Fu De Yang; Yunlong Tan; Shurong Jiang; Xiangyang Zhang; Xu-Feng Huang
Journal:  Sci Rep       Date:  2017-09-19       Impact factor: 4.379

6.  Classifying Schizophrenia Using Multimodal Multivariate Pattern Recognition Analysis: Evaluating the Impact of Individual Clinical Profiles on the Neurodiagnostic Performance.

Authors:  Carlos Cabral; Lana Kambeitz-Ilankovic; Joseph Kambeitz; Vince D Calhoun; Dominic B Dwyer; Sebastian von Saldern; Maria F Urquijo; Peter Falkai; Nikolaos Koutsouleris
Journal:  Schizophr Bull       Date:  2016-07       Impact factor: 9.306

7.  Using joint ICA to link function and structure using MEG and DTI in schizophrenia.

Authors:  J M Stephen; B A Coffman; R E Jung; J R Bustillo; C J Aine; V D Calhoun
Journal:  Neuroimage       Date:  2013-06-15       Impact factor: 6.556

8.  Assessing brain structural associations with working-memory related brain patterns in schizophrenia and healthy controls using linked independent component analysis.

Authors:  Christine Lycke Brandt; Nhat Trung Doan; Siren Tønnesen; Ingrid Agartz; Kenneth Hugdahl; Ingrid Melle; Ole A Andreassen; Lars T Westlye
Journal:  Neuroimage Clin       Date:  2015-08-21       Impact factor: 4.881

9.  Regional cortical thinning in young adults with schizophrenia but not psychotic or non-psychotic bipolar I disorder.

Authors:  Douglass Godwin; Kathryn I Alpert; Lei Wang; Daniel Mamah
Journal:  Int J Bipolar Disord       Date:  2018-07-11

10.  The Relationship Between White Matter Microstructure and General Cognitive Ability in Patients With Schizophrenia and Healthy Participants in the ENIGMA Consortium.

Authors:  Laurena Holleran; Sinead Kelly; Clara Alloza; Ingrid Agartz; Ole A Andreassen; Celso Arango; Nerisa Banaj; Vince Calhoun; Dara Cannon; Vaughan Carr; Aiden Corvin; David C Glahn; Ruben Gur; Elliot Hong; Cyril Hoschl; Fleur M Howells; Anthony James; Joost Janssen; Peter Kochunov; Stephen M Lawrie; Jingyu Liu; Covadonga Martinez; Colm McDonald; Derek Morris; David Mothersill; Christos Pantelis; Fabrizio Piras; Steven Potkin; Paul E Rasser; David Roalf; Laura Rowland; Theodore Satterthwaite; Ulrich Schall; Gianfranco Spalletta; Filip Spaniel; Dan J Stein; Anne Uhlmann; Aristotle Voineskos; Andrew Zalesky; Theo G M van Erp; Jessica A Turner; Ian J Deary; Paul M Thompson; Neda Jahanshad; Gary Donohoe
Journal:  Am J Psychiatry       Date:  2020-03-26       Impact factor: 18.112

View more
  2 in total

Review 1.  Progress and Pitfalls in Developing Agents to Treat Neurocognitive Deficits Associated with Schizophrenia.

Authors:  Tanja Veselinović; Irene Neuner
Journal:  CNS Drugs       Date:  2022-07-13       Impact factor: 6.497

2.  Relationships between cognitive performance, clinical insight and regional brain volumes in schizophrenia.

Authors:  Erkan Alkan; Simon L H Evans
Journal:  Schizophrenia (Heidelb)       Date:  2022-04-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.